Search Results - Anne Schuind

Enhanced passive surveillance of influenza vaccination in England, 2016−2017- an observational study using an adverse events reporting card by Simon de Lusignan, Filipa Ferreira, Silvia Damaso, Rachel Byford, Sameera Pathirannehelage, Anne Yeakey, Ivelina Yonova, Anne Schuind, Gael Dos Santos

Connect to this object online.

Retrospective study of the use of an influenza disease two-tiered classification system to characterize clinical severity in US children by Amber Hsiao, Philip O. Buck, Arnold Yee, John Hansen, Edwin M. Lewis, Laurie L. Aukes, Emad Yanni, Rafik Bekkat-Berkani, Anne Schuind, Nicola P. Klein

Connect to this object online.

Post hoc analysis of reactogenicity trends between dose 1 and dose 2 of the adjuvanted recombinant zoster vaccine in two parallel randomized trials by Romulo Colindres, Valentine Wascotte, Alain Brecx, Christopher Clarke, Caroline Hervé, Joon Hyung Kim, Myron J. Levin, Lidia Oostvogels, Toufik Zahaf, Anne Schuind, Anthony L. Cunningham

Connect to this object online.

Brand-specific enhanced safety surveillance of GSK's Fluarix Tetra seasonal influenza vaccine in England: 2017/2018 season by Simon de Lusignan, Silvia Damaso, Filipa Ferreira, Rachel Byford, Christopher McGee, Sameera Pathirannehelage, Vishvesh Shende, Ivelina Yonova, Alexander Schmidt, Anne Schuind, Gael Dos Santos

Connect to this object online.

The adjuvanted recombinant zoster vaccine is efficacious and safe in Asian adults ≥ 50 years of age: a sub-cohort analysis of the ZOE-50 and ZOE-70 randomized trials by Joon Hyung Kim, John Diaz-Decaro, Ning Jiang, Shinn-Jang Hwang, Eun Ju Choo, Maribel Co, Andrew Hastie, David Shu Cheong Hui, Junya Irimajiri, Jacob Lee, Edward Man-Fuk Leung, Haiwen Tang, Tomomi Tsuru, Philip Watson, Zhenhua Wu, Chong-Jen Yu, Yanfei Yuan, Toufik Zahaf, Anthony L. Cunningham, Anne Schuind

Connect to this object online.